How to Design a Custom Peptide

A custom peptide should be designed as an experimental reagent, then translated into a sequence a chemist can make. The reverse order—copying a protein fragment and adding a dye at the last minute—is how projects stall on insolubility, mispaired cysteines, or a label that occupies the binding residue.

This is a design checklist for research peptides. Manufacturing constraints are real and are discussed where they change the drawing. When the drawing is finished, send it as a custom peptide synthesis request rather than as a structure without termini or pairing notes.

Start from the measurement

Write one sentence: what will this peptide do in the experiment? Compete with a protein, raise an antibody, report a protease, immobilize on streptavidin, enter a cell in culture, or serve as an MS standard? Each use implies different termini, handles, and purity. A protease substrate needs a scissile bond and maybe a FRET pair. An antigen may need a terminal cysteine for carrier conjugation. An SPR ligand may need biotin on a long spacer so the epitope is not crushed against the chip.

If you cannot write that sentence, you are not ready to choose a fluorophore or a PEG length. Reagents accumulate; unused labeled peptides occupy freezer space and budgets.

Length, termini, and the fragment problem

Shorter peptides are easier to assemble and purify. They are also more likely to lack the conformation the protein context provided. There is no universal length. Epitope mapping often uses 12–20 residues with overlap (see peptide library formats). Helical motifs may need extra turns or a staple. Enzyme substrates can be very short if the recognition motif is compact.

N- and C-termini in a protein are not free amines and acids in the same way a fragment is. Acetylating the N-terminus and amidating the C-terminus removes extra charges and often better mimics an internal stretch. Leaving both termini free adds two charges and can help solubility at the cost of a less native electrostatics. Choose termini for the biology, then accept the solubility consequence or compensate with a charged tail that you understand.

C-terminal amides are a linker choice in SPPS, not a trivial extra. If a paper shows a free acid and you order an amide, you made a different molecule. Copy termini from the reference, not from a default form on a website.

Charge, hydrophobicity, and a solubility window

Count acidic and basic residues at the pH you will use. A peptide with no charge and a long hydrophobic stretch will fight every reconstitution. Tools that compute GRAVY or isoelectric point are starting points, not verdicts. Poly-histidine tails, oligo-lysine, or a few solubilizing residues outside the motif are legitimate design moves if you test that they do not destroy activity.

Aromatic stacking and β-branched runs (VVIV, IILL) are aggregation warnings for both synthesis and storage. If the motif requires them, plan a higher crude risk and a solubility protocol in advance. The later solubility guide is written for peptides that already exist; design time is cheaper.

Cysteine, methionine, and tryptophan as special cases

One cysteine is a conjugation handle. Two cysteines can form a disulfide—or a mixture of dimers and polymers if oxidation is uncontrolled. Three or more require a pairing map. Do not add a terminal Cys “just in case” on a peptide that already has internal cysteines unless you want a regioselectivity problem. For cyclic targets, decide the chemistry first using cyclic peptide synthesis notes, then place the Cys residues.

Methionine oxidizes. If the residue is not required, norleucine is a common research substitute that removes the sulfur. Tryptophan is sensitive in cleavage and in light-exposed solutions. If the assay does not need Trp fluorescence, consider whether the residue is load-bearing.

Handles: biotin, dyes, PEG, and extra lysines

Put the handle where the protein would tolerate an extension. An extra C-terminal lysine for FITC, with a short Ahx or PEG spacer, is a common pattern that keeps the motif intact. Labeling a lysine inside a nuclear-localization sequence changes the charge and the biology. Site-specific labeling is a modification design problem; the extra residue is part of the sequence, not an invisible tag.

Biotin without a spacer can weaken streptavidin presentation. PEG can hide a peptide from proteases and from the target. Fluorescent dyes add hydrophobicity and can cause aggregation that you will blame on the sequence. Choose the smallest handle that the instrument and the protein allow. Compare dyes in the FITC, TAMRA, and Cy5 comparison before you default to FITC because it is familiar.

Design choice	Question to answer	Typical mistake
Length	Does this fragment contain the functional motif?	Copying 40 residues when 14 would assay
Termini	Internal mimic or native protein end?	Default amide when the paper used acid
Cys	Handle, disulfide, or accident?	Extra Cys on an already Cys-rich chain
Label site	Is this residue required for binding?	FITC on a motif lysine
Solubilizing tail	Will KK or PEG change activity?	Adding tails after the peptide fails to dissolve
Purity	How would an impurity lie?	Ordering ≥98% for a first immunization

What to send when you request a quote

One block of text should contain: sequence in single- or three-letter code from N to C; termini; disulfide pairings; each modification with residue number; desired HPLC purity; quantity; salt form if not TFA; and the assay class in one phrase. If the peptide is part of a set of analogs, list them together so coupling and purification can be planned as a series. Use the quote form so attachments (a pairing scheme, a dye structure) stay with the request.

If a catalog sequence already matches, check whether a documented catalog lot exists first. Design work is for sequences that do not already exist as a released item.

Designed peptides remain research reagents. Design elegance does not confer suitability for human use.